Supplements
CJC-1295 Before and After: What Clinical Trials Actually Show
CJC-1295 is a synthetic growth hormone-releasing peptide that has gained a cult following in fitness and anti-aging circles, with before-and-after photos flooding social media. But the gap between anecdotal results and controlled clinical evidence is significant — and the legal, safety, and regulatory picture is complicated enough that anyone considering it deserves a clear-eyed look at the actual science.

CJC-1295 Before and After: What Clinical Trials Actually Show
Search 'CJC-1295 before and after' and you'll find thousands of transformation posts — leaner physiques, faster recovery, deeper sleep, more muscle. The peptide has a devoted following among biohackers, bodybuilders, and longevity enthusiasts. But clinical trials tell a more nuanced story, and the regulatory environment in the United States has grown significantly more restrictive. This article breaks down what the peer-reviewed evidence actually shows, what CJC-1295 is doing mechanistically, and what evidence-backed strategies exist for people who want similar outcomes through legal, well-studied means.
---
What Is CJC-1295 and How Does It Work?
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH). Unlike exogenous human growth hormone (HGH), which directly raises circulating GH, CJC-1295 works upstream — it binds to GHRH receptors in the pituitary gland and amplifies the natural pulsatile release of growth hormone. This distinction matters because pulsatile GH release is more physiologically normal than the sustained supraphysiologic spikes associated with exogenous HGH.
The original CJC-1295 formulation had a very short half-life of minutes. A modified version — CJC-1295 with DAC (Drug Affinity Complex) — binds to serum albumin, extending its half-life to approximately 6–8 days (Jetté et al., Journal of Clinical Endocrinology & Metabolism 2005; PMID: 16174719). This longer-acting version is what most anecdotal reports reference when people describe weekly injection protocols.
In terms of downstream effects, elevated GH stimulates hepatic production of insulin-like growth factor 1 (IGF-1), which mediates most of GH's anabolic and lipolytic effects: increased lean muscle protein synthesis, enhanced lipolysis (fat breakdown), and improved recovery from exercise-induced muscle damage.
---
What the Clinical Trials Actually Found
The most cited human trial on CJC-1295 DAC was conducted by Jetté and colleagues (2005; PMID: 16174719). In a randomized, double-blind, placebo-controlled study of 65 healthy adults aged 21–61, a single injection of CJC-1295 DAC produced a dose-dependent increase in mean GH levels of 2- to 10-fold above baseline. IGF-1 levels rose by 1.5- to 3-fold and remained elevated for 6–13 days. Importantly, this was achieved without significant adverse effects at lower doses, and GH remained in a pulsatile pattern rather than a flat elevation.
However — and this is critical — the trial measured GH and IGF-1 levels, not body composition outcomes like fat mass, lean mass, strength, or performance. The 'before and after' photographs you see online are extrapolating from hormonal biomarker data to physical transformation claims. That extrapolation has not been validated in published controlled trials specifically for CJC-1295.
A broader review of GHRH analogs in body composition research (Sattler et al., Journal of Clinical Endocrinology & Metabolism 2009; PMID: 19417040) found that GHRH stimulation did improve lean body mass and reduce fat mass in HIV-associated lipodystrophy — a specific clinical population with established GH deficiency — but cautioned against generalizing these results to healthy adults.
For context, a Cochrane-style review of GH and GHRH interventions in healthy older adults (Liu et al., Annals of Internal Medicine 2007; PMID: 17646604) found that while GH administration increased lean mass and reduced fat mass modestly, it did not translate to meaningful improvements in physical function, strength, or quality of life — and was associated with significant side effects including fluid retention, joint pain, and insulin resistance.
The takeaway: CJC-1295 reliably raises GH and IGF-1 in controlled settings. Whether that translates to the dramatic transformations seen in before-and-after photos remains unproven in healthy, exercising adults.
---
CJC-1295 Legal and Regulatory Status
In the United States, CJC-1295 is not FDA-approved for any indication. It was removed from compounding pharmacy lists by the FDA in 2023, making it no longer legal for licensed pharmacies to compound and dispense. This means that most products currently sold online are either research chemicals (not for human use) or exist in a legal gray zone. Athletes should also note that CJC-1295 is on the World Anti-Doping Agency (WADA) prohibited list under peptide hormones and growth factors.
This regulatory context is essential when evaluating before-and-after claims. Many of the people documenting results were using compounded products of unverified purity and dosing accuracy — variables that make it nearly impossible to attribute results cleanly to the peptide itself versus training, diet, or concurrent supplement use.
---
L-Tyrosine Before or After Workout: A Legal Alternative Worth Examining
While CJC-1295 targets the GH axis directly, some people exploring performance and body composition are drawn to amino acid precursors that modulate neurotransmitter and hormonal pathways. L-tyrosine is a precursor to dopamine, norepinephrine, and thyroid hormones (T3 and T4), making it relevant to both cognitive performance and metabolic rate.
A double-blind crossover study (Neri et al., Brain Research Bulletin 1995; PMID: 7620923) found that 150 mg/kg of tyrosine reduced performance decrements under sleep deprivation stress. More relevant to workout context, tyrosine supplementation has been shown to maintain cognitive performance under acute physical and cognitive stress — the kind of multitasking demands of training in a fatigued state.
For workout timing specifically, L-tyrosine taken 30–60 minutes before training is better supported by the evidence than post-workout use. Its benefits are largely cognitive and stress-buffering rather than directly anabolic, so framing it as a GH analog replacement would be inaccurate. That said, for people who valued CJC-1295's reported improvements in mental clarity and drive, L-tyrosine offers a legal, well-tolerated option at doses of 500–2000 mg.
---
Glycine Before or After Workout: Sleep, Recovery, and GH Release
Glycine is an underrated amino acid that intersects directly with the kind of outcomes CJC-1295 users often seek. Its most evidence-backed benefit in this context is sleep quality — and sleep is the primary physiological window for natural GH secretion.
A randomized, placebo-controlled trial (Bannai et al., Sleep and Biological Rhythms 2012; PMID: 23329818) found that 3g of glycine taken before bed significantly improved subjective sleep quality, reduced daytime sleepiness, and improved memory recognition the next morning. Since GH is predominantly secreted in slow-wave sleep, optimizing sleep architecture is one of the most potent natural levers for GH pulsatility.
For workout recovery specifically, glycine is a structural component of collagen, and research suggests it plays a role in connective tissue repair. A clinical trial (Shaw et al., American Journal of Clinical Nutrition 2017; PMID: 28177706) found that vitamin C–enriched gelatin (rich in glycine) consumed before exercise significantly increased collagen synthesis markers.
Timing-wise, 3g glycine before sleep appears optimal for the GH and sleep quality angle, while a smaller dose (5–10g in a collagen product) before exercise may support connective tissue. For more detail on glycine's clinical trial landscape, see our glycine interactions and clinical trial review.
---
Beta Alanine Before or After Workout: Buffering Fatigue Without Peptides
Beta-alanine is one of the most thoroughly studied ergogenic supplements, and it works through a completely different mechanism than GH-axis peptides. It raises intramuscular carnosine levels, which buffer hydrogen ion accumulation during high-intensity exercise — delaying the pH drop that causes muscular fatigue.
A meta-analysis of 40 randomized controlled trials (Hobson et al., Amino Acids 2012; PMID: 22270875) found that beta-alanine supplementation significantly improved exercise capacity in efforts lasting 60–240 seconds — the range that includes most high-intensity strength and conditioning work. Average performance improvement was approximately 2.85%, which is meaningful at competitive levels.
For timing, beta-alanine's mechanism is about chronic carnosine loading rather than acute ergogenic effects. Taking it pre-workout is conventional, but the evidence suggests consistent daily dosing (3.2–6.4g/day) matters more than the specific timing window. The characteristic tingling sensation (paresthesia) is benign and can be reduced by taking it with food or in split doses.
While beta-alanine won't replicate GH-axis stimulation, it directly addresses one of the core training goals CJC-1295 users often have: the ability to do more high-intensity work and recover faster between sets.
---
Citrulline Before or After Workout: Nitric Oxide and Blood Flow
L-citrulline is another supplement that targets workout performance through a distinct, well-documented mechanism. Citrulline raises plasma arginine levels more efficiently than arginine itself, boosting nitric oxide production, which dilates blood vessels and improves oxygen and nutrient delivery to working muscle.
A randomized, double-blind, placebo-controlled study (Pérez-Guisado & Jakeman, Journal of Strength and Conditioning Research 2010; PMID: 20386132) found that 8g citrulline malate taken before resistance training significantly reduced muscle soreness at 24 and 48 hours post-exercise and increased the number of repetitions completed compared to placebo.
For timing, pre-workout is optimal — 6–8g of L-citrulline or 8g of citrulline malate taken 30–60 minutes before exercise. Post-workout citrulline is less studied and less logically justified given the nitric oxide delivery mechanism.
For people who used CJC-1295 partly for the perceived improvement in pump, vascularity, and training endurance, citrulline provides direct, legally unambiguous, and well-documented benefits in those exact areas.
---
What This Means for Your Formula
Ones doesn't include CJC-1295 or any research-status peptide — and that's by design. The Ones model is built around clinically validated ingredients at doses that match the evidence, without the legal and safety risks of experimental compounds.
For people whose goals align with what CJC-1295 users typically seek — better body composition, recovery, sleep quality, and training performance — several ingredients in the Ones catalog directly address those pathways:
- Glycine (3g pre-sleep): Directly supports slow-wave sleep quality, which is the primary window for endogenous GH secretion. The Bannai et al. trial showing improved sleep architecture at this exact dose is reflected in how Ones incorporates glycine into recovery-focused formulas.
- Zinc (as zinc bisglycinate, 15–30mg): Zinc deficiency is associated with suppressed GH secretion and reduced IGF-1 levels. Ensuring adequate zinc status is a foundational step before exploring GH-axis peptides. For more on who should be cautious with zinc supplementation, see who should not take zinc.
- Rhodiola Rosea (standardized extract, 400mg): Supports physical endurance and stress resilience through adaptogenic mechanisms, complementing the fatigue-resistance goals many CJC-1295 users share.
Ones uses AI analysis of your bloodwork, wearable data, and health history to build a personalized formula — so if your labs show low zinc, disrupted sleep markers, or elevated cortisol, those gaps drive what goes into your capsules. That's a meaningfully different approach than a one-size-fits-all peptide protocol.
---
Key Takeaways
- CJC-1295 reliably raises GH and IGF-1 in controlled trials, but no published RCTs confirm the body composition changes shown in before-and-after photos in healthy adults.
- Legal status matters: CJC-1295 was removed from FDA-approved compounding in 2023 and is prohibited by WADA, making most available products legally and quality-questionable.
- Legal alternatives exist for each goal: Glycine for sleep/GH pulsatility, beta-alanine for training capacity, citrulline for performance and recovery, and L-tyrosine for cognitive resilience under training stress.
- Sleep quality is the most underutilized GH lever: Optimizing slow-wave sleep through glycine, magnesium, and sleep hygiene may produce GH-related benefits comparable to mild GHRH stimulation — without the regulatory and safety risk.
- Zinc adequacy is foundational: Sub-optimal zinc suppresses GH signaling; correcting a deficiency can meaningfully improve hormonal output before any other intervention.
- Personalized lab analysis matters: Since GH-axis function varies considerably between individuals, a data-driven approach — reviewing IGF-1, zinc status, and sleep quality markers — is a more rational starting point than any peptide protocol.
---
This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any new supplement or peptide protocol.